Tonix Pharmaceuticals Holding Corp. (TNXP)
10.87
-0.55
(-4.82%)
USD |
NASDAQ |
Sep 18, 16:00
10.90
+0.03
(+0.28%)
After-Hours: 20:00
Tonix Pharmaceuticals Market Cap : 182.53M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 182.53M |
| September 17, 2026 | 191.77M |
| September 16, 2026 | 197.48M |
| September 15, 2026 | 195.13M |
| September 14, 2026 | 196.97M |
| September 11, 2026 | 199.32M |
| September 10, 2026 | 206.21M |
| September 09, 2026 | 215.45M |
| September 08, 2026 | 220.99M |
| September 04, 2026 | 220.65M |
| September 03, 2026 | 224.51M |
| September 02, 2026 | 224.68M |
| September 01, 2026 | 234.76M |
| August 31, 2026 | 236.77M |
| August 28, 2026 | 228.21M |
| August 27, 2026 | 227.70M |
| August 26, 2026 | 229.05M |
| August 25, 2026 | 229.38M |
| August 24, 2026 | 209.06M |
| August 21, 2026 | 210.74M |
| August 20, 2026 | 208.06M |
| August 19, 2026 | 213.77M |
| August 18, 2026 | 212.59M |
| August 17, 2026 | 212.59M |
| August 14, 2026 | 213.43M |
| Date | Value |
|---|---|
| August 13, 2026 | 209.90M |
| August 12, 2026 | 201.00M |
| August 11, 2026 | 207.22M |
| August 10, 2026 | 211.42M |
| August 07, 2026 | 202.01M |
| August 06, 2026 | 195.63M |
| August 05, 2026 | 189.08M |
| August 04, 2026 | 159.24M |
| August 03, 2026 | 151.50M |
| July 31, 2026 | 142.20M |
| July 30, 2026 | 143.33M |
| July 29, 2026 | 135.09M |
| July 28, 2026 | 141.20M |
| July 27, 2026 | 147.31M |
| July 24, 2026 | 140.35M |
| July 23, 2026 | 150.86M |
| July 22, 2026 | 150.44M |
| July 21, 2026 | 164.21M |
| July 20, 2026 | 155.98M |
| July 17, 2026 | 176.57M |
| July 16, 2026 | 168.33M |
| July 15, 2026 | 164.92M |
| July 14, 2026 | 157.11M |
| July 13, 2026 | 166.27M |
| July 10, 2026 | 177.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Exelixis, Inc. | 14.52B |
| Inovio Pharmaceuticals, Inc. | 102.10M |
| Heron Therapeutics, Inc. | 58.68M |
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
Market Cap Related Metrics
| PS Ratio | 4.768 |
| Price to Book Value | 0.8212 |
| Price | 10.87 |
| Earnings Yield | -119.0% |